{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:51:24Z","timestamp":1767909084061,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.01.263","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T14:16:57Z","timestamp":1362665817000},"page":"2369-2374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model"],"prefix":"10.1016","volume":"168","author":[{"given":"Sandra","family":"Palus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jundong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse Z.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Culler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.01.263_bb0005","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and numbers","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.hco.0000221585.94490.09","article-title":"Prognosis and therapy approaches of cardiac cachexia","volume":"21","author":"Springer","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1054\/jcaf.2003.23","article-title":"Growth hormone resistance in chronic heart failure and its therapeutic implications","volume":"9","author":"Cicoira","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0025","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.sla.0000118561.54919.61","article-title":"Ghrelin: integrative neuroendocrine peptide in health and disease","volume":"239","author":"Wu","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221411794351897","article-title":"Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function","volume":"5","author":"Ledderose","year":"2011","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0040","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/hc3601.095575","article-title":"Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0045","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2008.06.094","article-title":"No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure","volume":"137","author":"Akashi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0055","doi-asserted-by":"crossref","first-page":"e26865","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-011-0029-3","article-title":"IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia","volume":"2","author":"Schmidt","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.ijcard.2013.01.263_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijcard.2011.07.056","article-title":"Analysis of liver metabolism in a rat model of heart failure","volume":"161","author":"Kato","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","article-title":"Ghrelin for cachexia","volume":"1","author":"Akamizu","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0115","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(97)24015-8","article-title":"Haemodynamic effects of intravenous growth hormone in congestive heart failure","volume":"349","author":"Volterrani","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0085","first-page":"433","article-title":"Risk factor paradox in wasting diseases","volume":"10","author":"Kalantar-Zadeh","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","article-title":"Cancer cachexia and fat\u2013muscle physiology","volume":"365","author":"Fearon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2004.06.020","article-title":"Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience\/biomaterial interface","volume":"190","author":"Whittlesey","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diab.35.6.692","article-title":"Controlled release of insulin from polymer matrices. Control of diabetes in rats","volume":"35","author":"Brown","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2013.01.263_bb0110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/exnr.2001.7778","article-title":"Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root","volume":"172","author":"Bloch","year":"2001","journal-title":"Exp Neurol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313003239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313003239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:38:14Z","timestamp":1759091894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313003239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313003239"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.263","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}